Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISHL12 2022 | Using appropriate criteria when selecting patients with HL for radiation therapy

In this video, Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, comments on the importance of achieving the best long-term results when treating patients with Hodgkin lymphoma (HL), cautioning clinicians against broadening the criteria that determine whether patients should receive radiation therapy, and instead advises for healthcare professionals to follow the criteria as determined in clinical trials. This interview took place at the 12th International Symposium on Hodgkin Lymphoma (ISHL12), held in Cologne, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Research funding from Seattle Genetics, BMS, Affimed, Regeneron, Takeda, AstraZeneca, Pfizer, ADC Therapeutics to my institution for clinical trials.